Geode Capital Management, LLC Harvard Bioscience Inc Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 892,627 shares of HBIO stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
892,627
Previous 856,224
4.25%
Holding current value
$2.13 Million
Previous $3.63 Million
29.94%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding HBIO
# of Institutions
106Shares Held
32.2MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$6.8 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$6.63 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.11 Million0.9% of portfolio
-
Amh Equity LTD2.39MShares$5.71 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.06 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $99.5M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...